Addressing The Challenges Mitigating Innovations In Pharmacy Practice In Nigeria A Focus On Research, Education and Manufacturing
Article Sidebar
Main Article Content
Abstract
ABSTRACT
This review addresses the current status of pharmacy practice in Nigeria, highlighting the significance of innovation and recognizing obstacles that impede advancement. In Nigeria, the pharmaceutical industry requires additional support in research and development (R&D), education, and manufacturing, despite the country's abundant resources and large population. The article provides actionable suggestions to tackle these problems and encourage creativity. Major areas that need improvement comprise boosting R&D capabilities through digital innovations and Artificial Intelligence (AI), revamping pharmacy education to be more inclined to industry demands, and encouraging domestic pharmaceutical manufacturing, with government policies. Issues like inadequate training in clinical pharmacy, restricted research chances for students, regulatory obstacles, and manufacturing quality assurance are being addressed. Recommendations provided by the authors include promoting partnerships between academia and industry, integrating subjects such as biotechnology and nanotechnology into pharmacy academic curricula, and enhancing local pharmaceutical manufacturing to reduce the dependence on imported drugs.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
REFERENCES
World Population Review. Nigeria. https://worldpopulationreview.com/countries/nigeria-population.
Nigeria resources and power. https://www.britannica.com/place/resources-and-power-nigeria.
Pharmaapproach. List of Pharmaceutical Companies in Nigeria. https://www.pharmapproach.com/list-of-pharmaceutical-companies-nigeria/
Okereke, M., Mashavakure, H.M. and Abdulwasiu, M.A.,(2022). An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?. INNOVATIONS in pharmacy, 13(1),10-10.: https://doi.org/10.24926/iip.v13i1.4656.
Furman ,J.L, & MacGarvie, M. J.(2007) Academic science and the birth of industrial research laboratories in the U.S. pharmaceutical industry,Journal of Economic Behavior & Organization, 63(4) , 756-776. https://doi.org/10.1016/j.jebo.2006.05.014.
Schuhmacher, A., Gassmann, O., Hinder, M. (2016),Changing R&D models in research-based pharmaceutical companies. Journal of Translational Medicine.(14) 1-11. https://doi.org/10.1186/s12967-016-0838-4.
Bunnage.E.M(2011). Getting pharmaceutical R&D back on target, nature chemical biology, 7(6), 335-339.
Kale, Dinar and Little, Steve (2007). From imitation to innovation: the evolution of R&D capabilities and learning processes in the Indian pharmaceutical industry. Technology Analysis and Strategic Management, 19(5)pp. 589-609. https://dx.doi.org/doi:10.1080/09537320701521317.
Merck Partners with Academic scientist and Biotechnology Entrepreneurs to create the California Institute for Biomedical Research (Calibr). https://www.merck.com/news/merck-partners-with-academic-scienist-and-biotechnology-entrepreneurs-to-create-the-california-institute-for-biomedical-research.
Pharmapproach. List of universities offering pharmacy programmes in Nigeria. https://www.pharmapproach.com/list-of-universities-offering-pharmacy-programmes-in-nigeria.
Harmonized curriculum for doctor of pharmacy(PharmD) training in ECOWAS region. https://www.wahooas.org/site/file.
O’ Connor, T.F. Lawrence.X.Y, & Lee, S.L(2016). Emerging technology: A key to enabler for modernizing pharmaceutical manufacturing and advancing product quality. Int. J. Pharm. 509(1-2), 492-498. https://doi.org/10.1016/j.ijpharm.2016.05.058.
Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachandran, R., & Ierapetritou, M.(2020). Digital twin in pharmaceutical and biopharmaceutical manufacturing: A literature review. processes 2020,8,1088. https://doi.org/10.3390/pr8091088.
Okereke, M., Adekunbi, A., & Ghazali, Y. (2021). Why Nigeria Must Strengthen its Local Pharmaceutical Manufacturing Capacity. INNOVATIONS in pharmacy, 12(4),3-3.https://doi.org/10.24926/iip.v12i4.4208.
Mallhi, T.H ., Liaqat, A., Abid, A., Khan, Y. H., Alotaibi, N. H., Alzarea, A.I., … & Khan, T. M. (2020) Multilevel engagements of pharmacists during the COVID-19 pandemic: the way forward. Frontiers in Public Health, 8, 561924. https://doi,org/10.3389/fpubh.2020.561924.
Egypt and Nigeria medicines regulators achieve high maturity level. https//www.who.int/egypt-and-nigeria-medicines-regulations-achieved-high-maturity-level.
Stakeholders raise alarm as local drug manufacturing nears collapse. https://www.guardian.ng/features/science/stakeholders-raises-alarm-as-local-drug-manufacturing-nears-collapse.
Import prohibition list - nigeria custom services. https://customs.gov.ng/?page_id=3075
Maskus, K,E. (2001). Parallel imports in pharmaceuticals: Implications for competition and prices in developing countries,’’ Final Report to World Intellectual Property Organization, 13.
Felton, L.A. (2013) Remington: Essentials of pharmaceutics. Philadelphia: Philadelphia College of Pharmacy. page 697
Pharmanews. API production plant: Emzor seals 14 Million Euros Deal with EIB. [Internet] https://pharmanewsonline.com/api-production-plant-emzor-seals-14-million-euro-deal-with-eib/